Statements (60)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:awards |
innovation awards
|
| gptkbp:businessModel |
partnerships
joint ventures licensing |
| gptkbp:clinicalTrials |
data analysis
regulatory compliance Phase II oncology patient recruitment reporting safety monitoring biostatistics Phase III data management Phase I protocol development site management clinical monitoring |
| gptkbp:collaborations |
pharmaceutical companies
research hospitals |
| gptkbp:community_engagement |
health initiatives
|
| gptkbp:conference |
biotechnology conferences
|
| gptkbp:employees |
50-100
|
| gptkbp:feedback |
patient safety
quality of life efficacy |
| gptkbp:focus |
biopharmaceuticals
|
| gptkbp:founded |
2012
|
| gptkbp:founder |
Lysandre_Labs_Team
|
| gptkbp:funding |
grants
investments |
| gptkbp:headquarters |
gptkb:Montreal,_Canada
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lysandre Labs
|
| gptkbp:industry |
healthcare
|
| gptkbp:investmentFocus |
venture capital firms
|
| gptkbp:location |
gptkb:North_America
|
| gptkbp:market |
gptkb:Asia
gptkb:North_America Europe |
| gptkbp:mission |
improve patient outcomes
|
| gptkbp:network |
biotech ecosystem
|
| gptkbp:partnerships |
academic institutions
|
| gptkbp:patentCitation |
biopharmaceutical inventions
|
| gptkbp:products |
biologics
|
| gptkbp:publications |
scientific journals
|
| gptkbp:regulatoryCompliance |
gptkb:FDA
gptkb:Health_Canada |
| gptkbp:research |
drug development
|
| gptkbp:research_areas |
gene therapy
immunotherapy vaccine development cell therapy |
| gptkbp:services |
clinical trials
|
| gptkbp:specialization |
therapeutics
|
| gptkbp:supportRole |
industry experts
|
| gptkbp:sustainability_initiatives |
environmental responsibility
|
| gptkbp:technology |
academic collaborations
biotechnology platforms |
| gptkbp:website |
www.lysandrelabs.com
|